S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.67 (-1.75%)
MSFT   416.22 (+0.62%)
META   501.57 (+0.27%)
GOOGL   154.94 (+0.05%)
AMZN   183.81 (+0.10%)
TSLA   156.61 (-3.02%)
NVDA   877.45 (+2.03%)
AMD   163.57 (+2.03%)
NIO   3.85 (-1.03%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.98 (+0.50%)
GE   156.75 (+1.98%)
CGC   6.80 (-2.58%)
DIS   114.03 (+0.96%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.17 (-0.43%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.67 (-1.75%)
MSFT   416.22 (+0.62%)
META   501.57 (+0.27%)
GOOGL   154.94 (+0.05%)
AMZN   183.81 (+0.10%)
TSLA   156.61 (-3.02%)
NVDA   877.45 (+2.03%)
AMD   163.57 (+2.03%)
NIO   3.85 (-1.03%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.98 (+0.50%)
GE   156.75 (+1.98%)
CGC   6.80 (-2.58%)
DIS   114.03 (+0.96%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.17 (-0.43%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.67 (-1.75%)
MSFT   416.22 (+0.62%)
META   501.57 (+0.27%)
GOOGL   154.94 (+0.05%)
AMZN   183.81 (+0.10%)
TSLA   156.61 (-3.02%)
NVDA   877.45 (+2.03%)
AMD   163.57 (+2.03%)
NIO   3.85 (-1.03%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.98 (+0.50%)
GE   156.75 (+1.98%)
CGC   6.80 (-2.58%)
DIS   114.03 (+0.96%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.17 (-0.43%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.67 (-1.75%)
MSFT   416.22 (+0.62%)
META   501.57 (+0.27%)
GOOGL   154.94 (+0.05%)
AMZN   183.81 (+0.10%)
TSLA   156.61 (-3.02%)
NVDA   877.45 (+2.03%)
AMD   163.57 (+2.03%)
NIO   3.85 (-1.03%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.98 (+0.50%)
GE   156.75 (+1.98%)
CGC   6.80 (-2.58%)
DIS   114.03 (+0.96%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.17 (-0.43%)
Free Trial

Cinemark (CNK) Stock Forecast & Price Target

→ Can't believe it's happening again (From Manward Press) (Ad)
Free cnk Stock Alerts
$18.22
+0.54 (+3.05%)
(As of 03:15 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Cinemark Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 9 Analyst Ratings

Analysts' Consensus Price Target

$19.56
7.33% Upside
High Forecast$24.00
Average Forecast$19.56
Low Forecast$12.00
TypeCurrent Forecast
4/17/23 to 4/16/24		1 Month Ago
3/18/23 to 3/17/24		3 Months Ago
1/17/23 to 1/17/24		1 Year Ago
4/17/22 to 4/17/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
Hold
3 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$19.56$17.40$17.80$17.13
Predicted Upside7.33% Upside11.29% Upside12.19% Upside15.32% Upside
Get Cinemark Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CNK and its competitors with MarketBeat's FREE daily newsletter.

CNK Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CNK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cinemark Stock vs. The Competition

TypeCinemarkConsumer Discretionary CompaniesS&P 500
Consensus Rating Score
2.44
2.54
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside7.33% Upside89.31% Upside11.53% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/10/2024Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$17.00 ➝ $19.00+2.26%
4/10/2024Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$22.00+15.30%
4/8/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral ➝ Neutral$17.00 ➝ $19.00-0.94%
4/5/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderweight ➝ Overweight$13.00 ➝ $23.00+22.67%
2/13/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform ➝ Outperform$20.00+30.98%
1/11/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetSell ➝ Sell$16.00 ➝ $12.00-13.29%
1/2/2024B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		E. Wold
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeBuy ➝ Neutral$23.00 ➝ $15.00+6.46%
8/7/2023Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform ➝ Outperform$20.00 ➝ $22.00+21.75%
8/7/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight ➝ Overweight$22.00 ➝ $24.00+33.48%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:33 PM ET.

CNK Price Target - Frequently Asked Questions

What is Cinemark's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for Cinemark stock is Hold based on the current 1 sell rating, 3 hold ratings and 5 buy ratings for CNK. The average twelve-month price prediction for Cinemark is $19.56 with a high price target of $24.00 and a low price target of $12.00. Learn more on CNK's analyst rating history.

Do Wall Street analysts like Cinemark more than its competitors?

Analysts like Cinemark less than other Consumer Discretionary companies. The consensus rating for Cinemark is Hold while the average consensus rating for consumer discretionary companies is Moderate Buy. Learn more on how CNK compares to other companies.

Is Cinemark being upgraded by Wall Street analysts?

Over the previous 90 days, Cinemark's stock had 1 upgrade by analysts.

Does Cinemark's stock price have much upside?

According to analysts, Cinemark's stock has a predicted upside of 13.67% based on their 12-month stock forecasts.

What analysts cover Cinemark?

Cinemark has been rated by Benchmark, JPMorgan Chase & Co., Roth Mkm, Wedbush, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:CNK) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Your eBook: Mastering Earnings Announcements Trading
StockEarnings
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing